Business Description
MYND Life Sciences Inc
NAICS : 325412
SIC : 3741
ISIN : CA62857B1094
Share Class Description:
MYNDF: Ordinary SharesCompare
Compare
Traded in other countries / regions
MYND.CanadaMYNDF.USA IPO Date
2021-06-30Description
MYND Life Sciences Inc is a medical biotech drug research and development company. The company is focused on neuro pharmaceutical and novel drug development, diagnostics, and vaccines and is developing new biological entities (NBEs) and new chemical entities (NCEs) and differentiates itself from other (bio)pharmaceutical companies by different molecular concepts for the applications of psilocybin analogs for overcoming diseases.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -7.92 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -10.91 | |||||
Piotroski F-Score | 5/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 18.91 | |||||
9-Day RSI | 20.69 | |||||
14-Day RSI | 22 | |||||
6-1 Month Momentum % | -17 | |||||
12-1 Month Momentum % | -4.23 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.11 | |||||
Quick Ratio | 0.11 | |||||
Days Payable | 1843.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -18.19 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -116.77 | |||||
ROIC % | -40.77 | |||||
ROC (Joel Greenblatt) % | -2000 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -17.79 | |||||
EV-to-EBITDA | -17.86 | |||||
EV-to-FCF | -22.12 | |||||
Earnings Yield (Greenblatt) % | -5.62 | |||||
FCF Yield % | -11.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MYNDF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
MYND Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.015 | ||
Beta | 0 | ||
Volatility % | 90.41 | ||
14-Day RSI | 22 | ||
14-Day ATR ($) | 0.000713 | ||
20-Day SMA ($) | 0.017715 | ||
12-1 Month Momentum % | -4.23 | ||
52-Week Range ($) | 0.0125 - 0.04 | ||
Shares Outstanding (Mil) | 47.82 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MYND Life Sciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MYND Life Sciences Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
MYND Life Sciences Inc Frequently Asked Questions
What is MYND Life Sciences Inc(MYNDF)'s stock price today?
The current price of MYNDF is $0.01. The 52 week high of MYNDF is $0.04 and 52 week low is $0.01.
When is next earnings date of MYND Life Sciences Inc(MYNDF)?
The next earnings date of MYND Life Sciences Inc(MYNDF) is .
Does MYND Life Sciences Inc(MYNDF) pay dividends? If so, how much?
MYND Life Sciences Inc(MYNDF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |